Clinical trials show weight loss between 15% to 21% for GLP-1s, but this study suggests that weight loss in the real world is considerably lower even for patients who have active prescriptions for an entire year
This holistic focus creates a balanced foundation for maintaining results, helping patients not just lose weight but also improve their overall well-being and confidence
Key results include an average body weight reduction of 14.9% at the 2.4mg weekly dose over 68 weeks
Edington CD, Chen WLK, Geishecker E, Kassis T, Soenksen LR, Bhushan BM, Freake D, Kirschner J, Maass C, Tsamandouras N, Valdez J, Cook CD, Parent T, Snyder S, Yu J, Suter E, Shockley M, Velazquez J, Velazquez JJ, Stockdale L, Papps JP, Lee I, Vann N, Gamboa M, LaBarge ME, Zhong Z, Wang X, Boyer LA, Lauffenburger DA, Carrier RL, Communal C, Tannenbaum SR, Stokes CL, Hughes DJ, Rohatgi G, Trumper DL, Cirit M, Griffith LG (2018) Interconnected microphysiological systems for quantitative biology and Pharmacology studies
Maintaining Your Dose: Long-Term Semaglutide Success Once you reach your therapeutic dose, you typically stay at that dose for 3 to 6 months to assess your weight loss trajectory and metabolic response